brain is directly responsible for the mental retardation observed in these patients. Indeed if the phenylalanine intake in the diet is decreased immediately after birth, the brain develops normally (4) . By analogy the mental retardation in Down syndrome patients may also be of metabolic origin. The metabolism of sulfur aminoacids is probably the source of the toxic compound.
The cystathionine beta synthase enzyme or CBS (EC 4.2.1.22) is encoded by a gene found on chromosome 21 (21 q 23) . Enzymatic activity of CBS increases by approximately 150% in the fibroblasts of Down syndrome patients compared to normal individuals (5) . The main function of CBS is to catalyze the first step of the transsulfurating pathway. This involves the hydrolysis of cystathionine by cystathionase or CST (EC 4.4.1.1). The in vivo increase in CBS activity induces a decrease in the CBS substrate (homocysteine) in the plasma of Down syndrome patients (6) . CBS also has another enzymatic activity, the production of H 2 S from cysteine (7) . Two other enzymes can also produce H 2 S: CST and mercaptopyruvate sulfur transferase (MPST: EC 2.8.1.2) (7). Mercaptopyruvate, the substrate of MPST, is obtained by transaminating cysteine. Studies on rats or man (8, 9) showed that after H 2 S poisoning the excretion of thiosulfate in urine is significantly increased. Thiosulfate is formed by the condensation of H 2 S and sulfite (SO 3 2-) which is produced by the thiol catabolism of cysteine (10) . In adult humans thiosulfate production is estimated to be 31 µmol/day (11 Summary Mental retardation is progressive in Down syndrome: individuals are born with normal intelligence which starts to decline linearly within the first year. This phenomenon can be observed with phenylalanine in patients with phenylketonuria, therefore it is compatible with metabolic intoxication. The toxic compound could be hydrogen sulfide. The amount of the compound is probably increased in Down syndrome by increasing active cystathionine beta synthase. This heuristic hypothesis requires further investigation. © 2001 Harcourt Publishers Ltd the tissues have been determined after exposure to large amounts of gaseous H 2 S, or after intraperitoneal administration of an equal amount of NaHS. The normal concentration of H 2 S in the rat brainstem is 1.23 ± 0.06 µg/g tissue (n = 10): the lethal concentration is only 5.00 ± 0.89 µg/g of brainstem tissue. The 50% lethal dose of NaHS is 16 mg/kg even though this dose only doubles the normal H 2 S concentration in the brain (12) . The lethal concentration is very close to the normal concentration, which explains its high toxicity. This toxicity in the central nervous system may be due, at least in part, to the action of H 2 S and HS -on cytochrome aa3 (12, 14, 15, 16) . Indeed, H 2 S is a more potent inhibitor of this cytochrome than cyanide (17) . However, there may be other explanations for H 2 S toxicity such as the formation of persulfides. Sulfhydryl modification leading to altered enzymatic function has been demonstrated for over a dozen enzymes after persulfide generation (18) . Similarly, sulfhydryl modification of receptor proteins by mercaptans which act as sulfide donors has been demonstrated (19) . H 2 S has also been shown to strongly inhibit human carbonic anhydrase (20) . Carbonic anhydrase resides mainly in glial cells, specifically in oligodendrocytes, and in hippocampal neurons (21) . It has also been demonstrated that monoamine oxidase is readily inactivated by sulfhydryl reagents, and high doses of NaHS are known to inhibit monoamine oxidase activity in a dose-dependent manner (22) . The half-life for the recovery of monoamine oxidase isolated from rat brain after irreversible inhibition is up to 30 days (23) . Chronic exposure to low concentrations (20 and 50 ppm) of hydrogen sulfide causes alterations in the central nervous system. To determine the effect of exposure during perinatal development pregnant rats were exposed to H 2 S 7 hours per day from Day 5 postcoitus, until Day 21 postnatal. H 2 S treatment produced severe alterations in the architecture and growth characteristics of the Purkinje cell dendritic fields (24) . Levels of serotonin and norepinephrine were determined in the rat cerebellum and frontal cortex during perinatal development. Concentrations of both amines were altered compared to the controls; serotonin levels were significantly increased at days 14 and 21 postnatal in both brain regions. Norepinephrine levels were significantly increased at days 7, 14 and 21 postnatal in the cerebellum, and at day 21 in the frontal cortex (25, 26) . It is well established that monoamines influence most aspects of neural development, including neural cell division, migration, morphogenesis and synapse formation. Serotonin is known to inhibit neurite outgrowth in the brains of developing rats probably via type a receptors (24) . H 2 S exposure may also alter monoamine levels in other brain regions such as the hippocampus (27) . Excessive increases in serotonin release in the hippocampus may cause learning deficits, by interacting with type II glucocorticoid receptors in the hippocampus (28) . This may explain the memory loss and the impaired cognitive and perceptual functions reported following H 2 S intoxication (29) . It is noteworthy that CBS is continuously and strongly expressed in the central nervous system of 28 human embryos from the earliest stage studied (22 days post conception) (30) . CBS gene expression was weak in the deep cerebellar nuclei of 25-week-old fetuses, and the strongest labeling was observed in the cerebellar cortex. It was recently discovered that Down syndrome patients have significantly smaller cerebellar volumes than matched controls, even after adjusting for total brain volume or total intracranial volume (Table 3 ) (31) . The specificity of the chronic toxic effect of H 2 S on the cerebellum (24) is consistent with this observation. The hyperproduction of H 2 S in Down syndrome patients could be related either to a direct effect of CBS on L-cysteine, or to an indirect effect of CBS hyperactivity by increasing cysteine production via an accelerated transsulfuration pathway. Thus the cysteine produced could be transaminated, and the mercaptopyruvate produced could become the substrate of MPST accompanying H 2 S production. Some studies indicate that endogenous H 2 S has a physiological function: acting as a smooth muscle relaxant in synergy with nitric oxide, or as an endogenous neuromodulator by inducing hippocampal long-term potentiation by enhancing NMDA receptor activity (32, 33) . Hyperproduction of H 2 S in Down syndrome could thus induce dysfunction in muscles (hypotonia) and brain (mental retardation). We have recently made important progress in this field by showing that thiosulfate urinary excretion is significantly increased (P < 0.01) in Down syndrome patients. Further studies are in progress to determine the concentration of H 2 S in the blood of these patients and to search for clinical signs of chronic H 2 S poisoning in Down syndrome patients. 
